The Benefits
Most Advanced Immune System Support*
Nearly all environmental threats contain proteins that the immune system must identify and break down. Enzymes that break down protein (proteolytic) can support this immune process.*
Enzyme Defense™ Extra Strength is 2x the potency of Enzyme Defense™
- Provides support to purify the body*
-
Assists in removing proteins that do not belong in the bloodstream.*
-
Naturally help break down excess mucus*
-
Promotes healthy circulation*
Usage & Notes
Recommended Use: 1 capsule twice daily on an empty stomach, one hour before or two hours after a meal.
Enzyme Defense is not an “immune stimulator,” rather a supporter of healthy immune function.*
Enzymedica does not use ingredients produced using biotechnology.
Consult with a physician prior to use if pregnant or nursing.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
The Science
Enzyme Defense™ Extra Strength is an improved version of Enzyme Defense. The enhanced formula contains a 60% increase of Serrapeptase (also known as Serratiopeptidase).
Enzymes can break down undigested food protein, cellular debris, and proteins that don’t belong in the bloodstream.*
Oral proteases, taken as a dietary supplement on an empty stomach, are absorbed and carried into the bloodstream where they are bound to plasma proteins known as Alpha-II-macroglobulin.(1)*
Recent research also indicates that the oral proteases bound to these plasma proteins can help break down harmful protein-based invaders in the blood.(2)*
The unique Enzyme Defense formula helps break down protein intruders in the bloodstream.*
- Protease
- Catalase
- Mucolase™
- Serrapeptase
These enzymes exhibit powerful antioxidant properties to help neutralize free radicals, digest mucus, encourage healthy circulation, and support systemic health.*
References
1 Muller, Lauer D. “Modulation of growth factor binding properties of alpha2-macroglubin by enzyme therapy.” Cancer Chemother Pharmacol. 47.Suppl 1 (2001): S4-9
2 Holomanova, Desser L. “Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.” Cancer Chemother Pharmacol. 47. Suppl 1 (2001): S10-5
